openPR Logo
Press release

Antacids Market to soar with CAGR of ~4% by 2025

03-15-2021 10:40 AM CET | Health & Medicine

Press release from: Fact.MR

Antacids Market

Antacids Market

Online pharmacies will grow as a prominent sales channel in the antacids market. A marked rise in the popularity of this channel is attributable to consumer-centric deals, such as attractive discounts and home delivery services. There is no permanent panacea for acid reflux and heartburn, which inadvertently is expected to retain consumers’ reliance on antacids.

This Press Release will help you to understand the market Statistics of European Region.

Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) at @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4328

The sustained rise in the demand for these drugs is encouraging manufacturers to take the research route to introduce effective novel drugs. Market players are disseminating information about the drug launch through the conduction of strategic marketing campaigns to boost their brand recognition. The relevance of these trends, along with futuristic ones, have been assessed in an extensive report published by Fact.MR. Authors of the report portend that, the antacids market will expand at an average CAGR of ~4% during the forecast period (2020-2025).

Key Highlights of Antacids Market Study

• Consumers’ inclination towards antacid tablets as a preferable formulation is projected to remain high, estimated to account for ~70% of the total share in the antacids market by 2025. Efforts made by manufacturers towards the development of chewable and flavored tablets will increase the demand for tablets during 2020-2025.
• Growing popularity of the self-medication trend and over-the-counter (OTC) availability of antacids are expected to unlock sales streams such as hospital pharmacies and retail pharmacies. Among these channels, retail pharmacies will account for one-third of the total sales generated by 2025.

For information on the Research Approach used in the Report, Ask for Methodology @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4328

• Sedentary lifestyles of consumers are leading to numerous cases of heartburn and acidity, given the long work hours and consumption of ready-to-eat meals with high preservatives. This is increasing consumers’ reliance on digestive remedies, and, in turn, thrusting the growth of the antacids market.
• In 2020, Proton Pump Inhibitors are projected to account for ~67% of the total market share, as these are widely acceptable drug classes for treatment of acid reflux. However, increasing information about the negative profile of these drugs is boosting the sales of H2 Antagonist.

Drug-induced Heartburn to Unfold New Growth Tangents for Market Players

The fragmented antacids market is attracting new entrants, owing to the easy availability of raw materials and low overhead costs. The possibilities of backward integration are extremely remote in the antacids market, given the high concentration of suppliers and low prices of raw materials. This instigates market players to position their brands with effective pricing and product differentiation strategies. Relaxed regulations for over-the-counter drugs have been supporting the distribution efforts of market players by increasing the penetration of antacids through online and offline sales channels.

Full Access of this Exclusive Report is Available at @ https://www.factmr.com/checkout/4328/S

Medications such as calcium channel blockers and beta blockers that are meant to relieve blood pressure increase stomach acid, which aggravates heartburn. In addition, bone-strengthening drugs such as bisphosphonates, risedronate, alendronate, and ibandronate that are consumed to treat osteoporosis lead to heartburn. These drugs, are, in turn, increasing the reliance of blood pressure patients on antacids.

In this intensely-competitive antacids market, besides research & development activities, distribution partnerships will bring in long-term growth opportunities.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4328/antacids-market
Content Source: https://www.factmr.com/media-release/1154/global-antacids-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacids Market to soar with CAGR of ~4% by 2025 here

News-ID: 2256266 • Views:

More Releases from Fact.MR

Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players include Actinium Pharmaceuticals, Inc., Alpha Tau Medical, Bayer AG, Fusion Pharmaceuticals, IBA Group, IBA Radiopharma Solutions, Lantheus Medical Imaging
10-01-2025 | Health & Medicine
Fact.MR
Muscle Stimulators Market is Valued USD 1.43 billion in 2025 | Key players inclu …
The global muscle stimulators market is set for significant expansion, with its valuation expected to increase from USD 1.43 billion in 2025 to USD 2.92 billion by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 7.4% over the forecast period from 2025 to 2035. The market's robust trajectory is driven by rising awareness of health and fitness, technological advancements in rehabilitation devices, and the increasing prevalence
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Becton, Dickinson and Company, Betterlifehealthcare Ltd., Cadwell Industries, Inc., Compumedics Ltd., GlaxoSmithKline, Inc., Hill-Rom Holdings
10-01-2025 | Health & Medicine
Fact.MR
Sleeping Aids Market to extend USD 131.3 Billion by 2035 | Abecca Healthcare, Be …
Fact.MR today unveiled its latest report on the Sleeping Aids Market, forecasting robust growth amid escalating sleep disorders, heightened stress levels, and a global push for restorative wellness solutions. Valued at USD 78.3 billion in 2025, the global market is projected to expand at a compound annual growth rate (CAGR) of 5.3%, reaching USD 131.3 billion by 2035. This trajectory reflects the market's pivotal role in addressing widespread insomnia, sleep
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; Salesforce; SAS; Oracle; Acoustic; Act-on Software; SendinBlue
Marketing Automation Market Will Hit USD 26.68 Billion by 2034 | Adobe; Hubspot; …
The global marketing automation market is experiencing robust growth, valued at USD 6.83 billion in 2024 and forecasted to reach USD 26.68 billion by 2034. This expansion reflects a compound annual growth rate (CAGR) of 14.6% over the forecast period from 2024 to 2034. The surge is primarily driven by the escalating demand for targeted advertising, enhanced user retention, and data-backed strategies in digital marketing channels. As internet penetration and
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, Driven by Digital Transformation and Hybrid Work Trends
Integrated Workplace Management System Market to Reach USD 10.6 Billion by 2034, …
The global Integrated Workplace Management System (IWMS) market is experiencing significant growth, with projections indicating an increase from approximately USD 4 billion in 2024 to USD 10.6 billion by 2034, reflecting a compound annual growth rate (CAGR) of 10.2% over the period from 2025 to 2034. This expansion is attributed to the rising demand for automation in facility management, the adoption of digital workplace solutions, and the need for efficient

All 5 Releases


More Releases for Antacids

Rising Incidence Of Acidity Due To Unhealthy Lifestyles Boosts Antacids Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Antacids Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the antacids market has been demonstrating steady growth. The market value is projected to increase from $9.63 billion in 2024 to $9.94 billion in 2025, exhibiting a Compound Annual Growth Rate
Mouth-Melting Antacids Revolutionize The Market Industry Trends Gaining Momentum …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Antacids Market Through 2025? In the past few years, the size of the antacids market has demonstrably increased. It is projected to rise from $9.54 billion in 2024 to $9.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.8%.
Antacids Tablets Market Future Prediction Report By 2033
The Antacids Tablets Market was valued at USD 6.92 billion in 2023, and it is projected to reach USD 12.01 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033. Antacids Tablets Market Overview The Antacids Tablets Market is experiencing steady growth due to the rising prevalence of acid reflux, indigestion, and gastrointestinal disorders across the globe. Increasing consumption of fast food, stressful lifestyles, and higher awareness about digestive
Rising Incidence Of Acidity Due To Unhealthy Lifestyles Boosts Antacids Market: …
The Antacids Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Antacids Market Size and Projected Growth Rate? The market for antacids has experienced consistent growth in the past few years. The market's value is predicted to escalate from $9.54 billion in 2024 to
North America Antacids Market Prospects and Growth Assessment 2027
The North America antacids market is expected to reach US$ 3,564.22 million in 2027 from US$ 2,684.67 million in 2019. The market is estimated to grow with a CAGR of 3.7% from 2020-2027. The Report North America Antacids Market study by "Business Market Insights" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and
Antacids Market Growth Size, Share |Trend 2030
Exclusive Report by Ameco Research: Antacids Market Size Projected to Reach USD 10 Billion by 2030, Growing at 4.40% CAGR Ameco Research is proud to announce the launch of its latest market research report, Antacids Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research reports to